Anti-ulcerogenic properties of endothelin receptor antagonists in the rat

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 4, 1999, Pages 537-544

  Padol, I ^a   Huang, J Q ^a   Hunt, R H ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRIDYLCARBAMIC ACID 2 [[5 (2 METHOXYPHENOXY) 6 [[(4 ISOPROPYLPHENYL)SULFONYL]AMINO] 2 MORPHOLINO 4 PYRIMIDINYL]OXY]ETHYL ESTER; ANTIULCER AGENT; BOSENTAN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; MYELOPEROXIDASE; STOMACH SECRETION INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; DRUG POTENCY; ENZYME ACTIVITY; IMMOBILIZATION STRESS; MALE; MICROCIRCULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH BLOOD FLOW; STOMACH INJURY; STOMACH LESION; STOMACH ULCER; WATER IMMERSION;

ANIMALS; ANTI-ULCER AGENTS; DISEASE MODELS, ANIMAL; INDOMETHACIN; MALE; MICE; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; STOMACH ULCER; STRESS; SULFONAMIDES;

EID: 0032942944     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00503.x     Document Type: Article

References (50)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vosoconstrictor peptide produced by vascular endothelial cells. Nature (London) 1988; 332: 411-15.
2. Whittle BJR, Esplugues JV. Induction of rat gastric damage by the endothelium-derived peptide, endothelin. Br J Pharmacol 1988; 95: 1011-13.
3. Wallace JL, Keenan CM, McNaughton WK, McKnight GW. Comparison of the effects of endothelin-1 and endothelin-3 on the rat stomach. Eur J Pharmacol 1989; 167: 41-7.
4. Lazaratos S, Kashimura H, Nakahara A, et al. Gastric ulcer induced by submucosal injection of ET-1: Role of potent vasoconstriction and intraluminal acid. Am J Physiol 1993; 265: G491-8.
5. Ota S, Hirata Y, Sugimoto T, et al. Endothelin-1 secretion from cultured rabbit gastric epithelial cells. J Cardiovasc Pharmacol 1991: 17(Suppl. 7): S406-7.
6. Ehrenreich H, Anderson RW, Fox CH, et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172: 1741-8.
7. Sessa WC, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991; 174: 613-18.
8. Akimoto M. Endothelin levels under water-immersion stress in rats. Jpn J Gastroenterol 1992; 89: 1982-9.
9. Masuda E, Kawano S, Michida T, et al. Plasma and gastric mucosal endothelin-1 concentrations in patients with peptic ulcer. Dig Dis Sci 1997; 42: 314-18.
10. Michida T, Kawano S, Masuda E, et al. Endothelin-1 in the gastric mucosa in stress ulcers in critically ill patients. Am J Gastroenterol 1997; 92: 1177-81.
11. Masuda E, Kawano S, Nagano K, et al. Role of endogenous endothelin in the pathogenesis of ethanol-induced gastric mucosal injury in rats. Am J Physiol 1993; 265: G474-81.
12. Kitajima T, Yamaguchi T, Tani K, et al. Role of endothelin and platelet-activating factor in indomethacin-induced gastric mucosal injury in rats. Digestion 1993; 54: 156-9.
13. Morales RE, Johnson BR, Szabo S. Endothelin induces vascular and muscosal lesions, enhances the injury by HCl/ethanol, and the antibody exerts gastroprotection. FASEB J 1992; 6: 2354-60.
14. Traish AM, Moran M, Saenz de Tejada I. Physicochemical characterization and solubilization of endothelin receptors. Receptor 1991; 1: 229-42.
15. Urade Y, Fujitani Y, Oda K, et al. An endothelin B receptor-selective antagonist: TRI 1038,[Cys11-Cys15] endothelin-1 (11-21). FEBS Lett 1992; 311: 12-16.
16. C receptor) form xenopus laevis dermal melanophores. J Biol Chem 1993; 268: 19126-33.
17. Michida T, Kawano S, Masuda E, et al. Role of endothelin-1 in haemorrhagic shock-induced gastric mucosal injury in rats. Gastroenterology 1994; 106: 988-93.
18. Kurihara T, Akimoto M, Kurokawa K, et al. ET-3 sensitive reduction of tissue blood flow in rat liver. Life Sci 1992; 51: PL101-6.
19. Takagi K, Okabe S. The effects of drugs on production and recovery process of the stress ulcer. Jpn J Pharmacol 1968; 18: 9-18.
20. Wallace JL, Keenan CM. An orally active inhibitor of leukotrine syntesis accelerates healing in a rat model of colitis. Am J Physiol 1990; 258: G527-34.
21. Wallace JL, Keenan CM, Cucala M, et al. Mechanisms underlying the protective effects of interleukin 1 in the experimental nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 1992; 102: 1176-85.
22. Berglindh T. Gastric glands and cells: Preparation and in vitro methods. Methods Enzymol 1990; 192: 93-107.
23. Said SA, El-Mowafy AM. Role of endogenous endothelin in stress-induced gastric mucosal damage and acid secretion in rats. Reg Peptides 1998; 73: 43-50.
24. Fukumura D, Kurose I, Miura S, et al. Role of endothelin-1 in repeated electrical stimulation-induced microcirculatory disturbance and mucosal damage in rat stomach. J Gastroenterol Hepatol 1996; 11: 279-85.
25. Lazaratos S, Nakahara, Goto K, Fukutomi H. Bosentan antagonizes the effects of endothelin-1 on rat gastric blood flow and mucosal integrity. Life Sci 1995; 56: 195-200.
26. Saeki Y, Arakawa T, Higuchi K, et al. Effects of endothelin on serum gastrin level and acid secretion in rats. J Cardiovosc Pharmacol 1995; 26(Suppl. 3): S123-5.
27. - channel couples to endothelin B receptors in the basolateral membrane of guinea-pig parietal cells. J Physiol 1995; 488: 65-75.
28. +-ATPase inhibitor, in rats and dogs. Jpn J Pharmacol 1995; 67: 50-67.
29. +-ATPase) inhibitor, TY-11345 in experimental animals. Jpn J Pharmacol 1993; 62: 363-71.
30. Goto H, Sugiyama S, Tsukamoto Y, et al. Effects of two benzimidazoles as proton pump inhibitors on water immersion stress-induced gastric ulcers in rats. Arzneim Forsh/Drug Res 1991; 41: 635-7.
31. Gerkens JF, Shand DG, Flexner C, et al. Effect of indomethacin and aspirin on gastric flow and acid secretion. J Pharmacol Exp Ther 1977; 203: 646-52.
32. Ohta M, Nguyen TH, Tamawski A, et al. Overexpression of endothelin-1 mRNA and protein in portal hypertensive gastric mucosa of rats: A key to increased susceptibility to damage? Surgery 1997; 12: 936-42.
33. Günal Ö, Yeǧen C, Aktan AÖ, et al. Gastric functions in portal hypertension. Role of endothelin. Dig Dis Sci 1996; 41: 585-90.
34. Matsumaru K, Kashimura H, Hassan M, et al. Bosentan, a novel synthetic mixed-type endothelin receptor antagonist, attenuates acute gastric mucosal lesions induced by indomethacin and HC1 in the rat: Role of endogenous endothelin-1. J Gastroenterol 1997; 32: 164-70.
35. Hassan M, Kashimura H, Matsumanu K, et al. Gastric mucosal injury induced by local ischemia-reperfusion in rats. Role of endogenous endothelin-1 and free radical. Dig Dis Sci 1997; 42: 1375-80.
36. Hogaboam CM, Muller MJ, Collins SM, Hunt RH. An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis. Eur J Pharmacol 1996; 309: 261-9.
37. Padol I, Huang JQ, Hogaboam CM, Hunt RH. Therapeutic effect of endothelin receptor antagonist Ro 48-5695 in rat model of colitis. Gastroenterology 1998; 114: A1057 (Abstract).
38. A receptor required for interaction with bosentan. Eur J Pharmacol 1994; 269: 225-34.
39. 2. Eur J Pharmacol 1994; 252: 81-6.
40. A receptor. Life Sci 1992; 50: 247-55.
41. Takayanagi R, Kitazumi K, Takasaki C, et al. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett 1991: 282: 103-6.
42. Clozel M, Gray GA, Breu V, et al. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Common 1992; 186: 867-73.
43. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89: 1203-8.
44. Elferink JGR, de Koster BM. Endothelin-induced activation of neutrophil migration. Biochem Pharmacol 1994; 48: 865-71.
45. Wright CD, Cody WL, Dunbar JB, et al. Characterization of endothelins as chemoattractants for human neutrophils. Life Sci 1994; 55: 1633-41.
46. Elferink JGR, de Koster BM. Stimulation and inhibition of neutrophil chemotaxis by endothelin-3. J Cardiovasc Pharmacol 1995; 26(Suppl. 3): S142-4.
47. Ishida K, Takeshige K, Minakami S. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenyl-alanine. Biochem Biophys Res Commun 1990; 173: 496-500.
48. Anthony A, Dhillon AP, Nygard G, et al. Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther 1993; 7: 29-40.
49. McMillen MA, Sumpio BE. Endothelins: Polyfunctional cytokines. J Am Coll Surg 1995; 180: 621-37.
50. Matsumaru K, Kashimura H, Hassan M, et al. Phosphoramidon, an inhibitor of endothelin converting enzyme, prevents indomethacin-induced gastric mucosal damage in rats. Pharmacol Lett 1998; 62: PL79-84.